title: The use of prostaglandins in controlling estrous cycle of the ewe: a review.
abstract: This review considers the use of prostaglandin F(2α) and its synthetic analogues (PG) for controlling the estrous cycle of the ewe. Aspects such as phase of the estrus cycle, PG analogues, PG doses, ovarian follicle development pattern, CL formation, progesterone synthesis, ovulation rate, sperm transport, embryo quality, and fertility rates after PG administration are reviewed. Furthermore, protocols for estrus synchronization and their success in timed AI programs are discussed. Based on available information, the ovine CL is refractory to PG treatment for up to 2 days after ovulation. All PG analogues are effective when an appropriate dose is given; in that regard, there is a positive association between the dose administered and the proportion of ewes detected in estrus. Follicular response after PG is dependent on the phase of the estrous cycle at treatment. Altered sperm transport and low pregnancy rates are generally reported. However, reports on alteration of the steroidogenic capacity of preovulatory follicles, ovulation rate, embryo quality, recovery rates, and prolificacy, are controversial. Although various PG-based protocols can be used for estrus synchronization, a second PG injection improves estrus response when the stage of the estrous cycle at the first injection is unknown. The estrus cycle after PG administration has a normal length. Prostaglandin-based protocols for timed AI achieved poor reproductive outcomes, but increasing the interval between PG injections might increase pregnancy rates. Attempts to improve reproductive outcomes have been directed to provide a synchronized LH surge: use of different routes of AI (cervical or intrauterine), different PG doses, and increased intervals between PG injections. Finally we present our point of view regarding future perspectives on the use of PG in programs of controlled sheep reproduction.
authors.affiliation: Departamento de Salud en los Sistemas Pecuarios-Área de Producción y Sanidad Ovina-Instituto de Producción Animal-Facultad de Veterinaria, Paysandú, Uruguay. sfierro33@gmail.com
authors.forename: Sergio
authors.initials: S
authors.lastname: Fierro
authors.forename: Jorge
authors.initials: J
authors.lastname: Gil
authors.forename: Carolina
authors.initials: C
authors.lastname: Viñoles
authors.forename: Julio
authors.initials: J
authors.lastname: Olivera-Muzante
mesh_terms: D000818:Animals; D003338:Corpus Luteum / Q000187:drug effects / Q000502:physiology; D015237:Dinoprost / Q000008:administration & dosage / Q000031:analogs & derivatives; D004305:Dose-Response Relationship, Drug; D030762:Estrous Cycle / Q000187:drug effects*; D004973:Estrus Synchronization / Q000379:methods; D005260:Female; D007315:Insemination, Artificial / Q000379:methods / Q000662:veterinary; D008297:Male; D006080:Ovarian Follicle / Q000187:drug effects / Q000254:growth & development; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011453:Prostaglandins / Q000008:administration & dosage*; D012756:Sheep / Q000502:physiology*; D013083:Sperm Transport / Q000187:drug effects
chemical_list: D011453:Prostaglandins; D011374:Progesterone; D015237:Dinoprost